TRL, funded by the European Commission, is evaluating the WorldSID 5th female in the areas of multipoint chest deflection measurement, biofidelity, and injury risk.

To evaluate multi-point chest deflection measurement in the 5th female, TRL is investigating implementing the RibEye. This may allow better replication of Post Mortem Human Subject (PMHS) tests and improve existing injury risk functions. Overall the group felt this work is important, but there have been difficulties in implementation due to some technical challenges and funding.

With regard to biofidelity TRL will contribute to the ISO WG5 scaling activities by conducting pendulum or sled tests as appropriate. TRL will also work with the ISO WG6 to develop injury risk curves, the ISO group taking the lead on coordination.